ESC Premium Access

Is there a need to revise the ESC Guidelines for myocardial revascularisation and chronic coronary syndromes because of the ISCHEMIA trial?

Congress Session

About the speaker

Doctor Bernard Gersh

Mayo Clinic, Rochester (United States of America)
5 presentations
0 follower

4 more presentations in this session

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

Speaker: Assistant Professor S. Kohsaka (Tokyo, JP)

Thumbnail

How should we manage chronic coronary syndromes after the ISCHEMIA trial?

Speaker: Doctor F. Otsuka (Suita, JP)

Thumbnail

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

Thumbnail

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial - Chat Moderator.

Thumbnail

Access the full session

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial

Speakers: Doctor B. Gersh, Assistant Professor S. Kohsaka, Doctor F. Otsuka
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Timing and indication of intervention in asymptomatic patients with valvular heart disease.

28 August 2021

ESC Premium Access

Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.

27 August 2021

ESC Premium Access

Colchicine in Acute Myocardial Infarction

27 August 2021

This platform is supported by

logo Novo Nordisk